|
MBD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6278089987054E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.31654711974261E-13 |
| Normal-vs-Stage2 |
2.64650000025846E-07 |
| Normal-vs-Stage3 |
1.11932685342708E-12 |
| Normal-vs-Stage4 |
3.9430003706542E-10 |
| Stage1-vs-Stage2 |
9.037400E-01 |
| Stage1-vs-Stage3 |
1.502840E-01 |
| Stage1-vs-Stage4 |
3.773000E-01 |
| Stage2-vs-Stage3 |
4.240400E-01 |
| Stage2-vs-Stage4 |
5.855200E-01 |
| Stage3-vs-Stage4 |
8.379600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.88578058618805E-15 |
| Normal-vs-AfricanAmerican |
5.755700E-04 |
| Normal-vs-Asian |
5.55429999993251E-07 |
| Caucasian-vs-AfricanAmerican |
1.016640E-01 |
| Caucasian-vs-Asian |
1.319840E-01 |
| AfricanAmerican-vs-Asian |
6.263200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.82853773525949E-12 |
| Normal-vs-Female |
1.64734892393881E-12 |
| Male-vs-Female |
9.687400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.51865195366463E-12 |
| Normal-vs-Age(41-60Yrs) |
1.9665047368278E-11 |
| Normal-vs-Age(61-80Yrs) |
7.15838499587562E-12 |
| Normal-vs-Age(81-100Yrs) |
2.954500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.678000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.726000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.783200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.810400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.946000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.880600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.722810E-03 |
| Classical-VS-Follicular |
9.544400E-02 |
| Classical-VS-Other |
2.919000E-01 |
| Classical-VS-Normal |
2.22688534279314E-12 |
| Tall-VS-Follicular |
1.170760E-01 |
| Tall-VS-Other |
5.711800E-01 |
| Tall-VS-Normal |
1.30762067840351E-12 |
| Follicular-VS-Other |
8.096600E-01 |
| Follicular-VS-Normal |
2.85089996054921E-09 |
| Other-VS-Normal |
8.567500E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.7454709312974E-12 |
| Normal-vs-N1 |
3.98159949455135E-10 |
| N0-vs-N1 |
3.076000E-01 |
|
|
